HAS vs REGN · P/E 25, rev $4.75B vs P/E 14, rev $14.34B
Hasbro Inc (HAS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Hasbro Inc (HAS) is a leisure company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported HAS revenue for 2024-12-29 was $4.75B. Net income was $394.4M. Revenue was down 16.9% from 2023-12-31 to 2024-12-29. HAS currently screens at market cap $10.75B and trailing P/E 25.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
HAS currently screens at market cap $10.75B and trailing P/E 25.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the HAS and REGN stock pages for the full models.
Not investment advice.